DENMARK – Novo Nordisk has announced that Health Canada has approved Wegovy (semaglutide injection), the first and only prescription weight-loss medication with a once-weekly dosing schedule. Wegovy is indicated for…
Read MoreNovo Nordisk’s high-dose obesity drug, Wegovy approved in Canada
